Chenhui Deng

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw et al. · Clinical Cancer Research · 2020 · 108 citations · Full text

Medicine, Oncology, Pharmacology +15

Accurate operation delay prediction for FPGA HLS using graph neural networks

Ecenur Ustun, Chenhui Deng, Debjit Pal et al. · 2020 · 66 citations

Engineering, Computer Engineering, Computer Science +15

Layout Symmetry Annotation for Analog Circuits with Graph Neural Networks

Xiaohan Gao, Chenhui Deng, Mingjie Liu et al. · 2021 · 30 citations

Computing, Computer Science, Electrical Engineering +15

A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats

Liang Li, Zaiquan Li, Chenhui Deng et al. · Acta Pharmacologica Sinica · 2012 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis

Chenhui Deng, Taotao Liu, Tianyan Zhou et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 27 citations

Pharmacy, Pharmacokinetics, Pharmacology +17